· Venture Capital Tracker · investment-strategies  · 1 min read

NVCA 2026 Yearbook: A Venture Industry in Transition — Fewer Funds, Bigger Winners

NVCA's 2026 Yearbook shows $67B raised across 585 U.S. funds in 2025, with the top 10 funds capturing a disproportionate share — a clear structural shift.

The National Venture Capital Association’s 2026 Yearbook describes a venture industry in transition: $67B raised across 585 U.S. funds in 2025, with a disproportionate share flowing to the top 10 funds.

What the data actually shows

  • Fund count: 585 U.S. VC funds raised capital in 2025 — well below 2021’s peak.
  • Concentration: A small number of mega-funds captured an outsize share of commitments, mirroring the concentration dynamics at the portfolio level.
  • Exit environment: IPO windows are opening selectively; sponsor-backed M&A and private secondary markets fill the gap.

Implications for GPs

  1. Emerging managers: Fundraising remains difficult but not impossible — LPs are concentrating bets on known quantities with clean DPI.
  2. Established GPs: Easier to raise larger funds, but portfolio construction must justify scale.
  3. Strategy: Clear sector thesis, repeatable sourcing, and strong platform/operator support are increasingly LP expectations.

Implications for founders

  • Expect fewer, bigger checks at Series A and beyond from top-tier funds.
  • Second-tier funds are leaner — more disciplined on valuation, faster to due-diligence teams with traction.

Practical takeaway

  1. GPs: Publish quarterly LP updates with DPI trajectories, not TVPI hopes.
  2. Founders: Optimize your list for check size fit, not brand.

Sources

  1. NVCA 2026 Yearbook release: https://nvca.org/press_releases/nvca-releases-2026-yearbook-charts-a-venture-industry-in-transition/

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Back to Blog

Recommended next

Browse all research »

How Much Did AusperBio Raise? $120M Series C, No Valuation

AusperBio closed a $120 million Series C on August 27, 2026. An unnamed strategic investor led. RA Capital joined. The company cites $360 million raised since 2024. Valuation was not disclosed. AHB-137 is in Phase 3 in China and remains investigational.